Italy to take legal action against vaccine makers over delays

Pfizer had said it was slowing supplies to Europe

January 24, 2021 10:07 pm | Updated 10:07 pm IST - Milan

Italy will take legal action against Pfizer Inc and AstraZeneca over delays in deliveries of COVID-19 vaccines to secure agreed supplies rather than seek damages, Foreign Minister Luigi Di Maio said on Sunday.

“We are working so our vaccine plan programme does not change,” Mr. Di Maio said on RAI state television.

On Saturday, Italian Prime Minister Giuseppe Conte said the delays in vaccine supplies were “unacceptable” and amounted to a serious breach of contractual obligations, adding that Italy would use all available legal tools.

Italy will have to rethink its whole vaccination programme if supply problems persist, a senior health official warned.

Asked why he thought the pharmaceutical companies had beenforced to announce reductions, Mr. Di Maio said he believed they had simply bitten off more than they could chew.

“We are activating all channels so the EU Commission does all it can to make these gentlemen respect their contracts,” he said.

Pfizer last week said it was temporarily slowing supplies to Europe to make manufacturing changes that would boost output.

On Friday, a senior official told Reuters that AstraZeneca had also informed the European Union it would cut deliveries of its COVID-19 vaccine to the bloc by 60% because of production problems.

The cut in supplies announced by the two companies will put back vaccination of those aged 80 and above in Italy by about four weeks and the rest of the population by about 6-8 weeks, Deputy Health Minister Pierpaolo Sileri said.

“This kind of delay affects the whole of Europe and a good part of the world,” he said.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.